Page last updated: 2024-12-05

chloromethyl methyl ether

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

chloromethyl methyl ether: was MH 1977-92 (see under METHYL ETHERS 1977-90); METHOXYCHLOROMETHANE & METHYL CHLOROMETHYL ETHER were see CHLOROMETHYL METHYL ETHER 1977-92; use METHYL ETHERS to search CHLOROMETHYL METHYL ETHER 1977-92; an alpha halo ether alkylating agent used widely in chemical & plastic industries; it causes lung hyperplasias & neoplasms & skin neoplasms [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID7864
CHEMBL ID3185256
CHEBI ID82271
MeSH IDM0198272

Synonyms (100)

Synonym
methoxymethylchloride
ether, chloromethyl methyl
dimethylchloroether
chlorodimethyl ether
107-30-2
monochlorodimethyl ether
ether methylique monochlore
methoxychloromethane
chloromethyl methyl ether
methyl chloromethyl ether
cmme
methoxymethyl chloride
nsc21208
.alpha.,.alpha.-dichlorodimethyl ether
methyl chloromethyl ether, anhydrous
ether, dimethyl chloro
monochloromethyl methyl ether
chloromethoxymethane
chlordimethylether
wln: g1o1
nsc-21208
methylchloromethyl ether
un1239
ccris 138
rcra waste number u046
rcra waste no. u046
ether methylique monochlore [french]
chloromethyl methyl ether (technical grade)
brn 0505943
chlordimethylether [czech]
nsc 21208
methyl chloromethyl ether [un1239] [poison]
hsdb 908
einecs 203-480-1
alpha,alpha-dichlorodimethyl ether
nsc93873
nsc-93873
inchi=1/c2h5clo/c1-4-2-3/h2h2,1h
methane, chloromethoxy-
chloro(methoxy)methane
chloromethyl methyl ether, technical grade
chloromethyl methyl ether (cmme)
AKOS000121040
NCGC00249073-01
chloromethylmethyl ether
methyl chloromethyl ether [un1239] [poison]
unii-334g5b96vg
334g5b96vg ,
C19160
tox21_302939
NCGC00256384-01
dtxcid40307
dtxsid6020307 ,
cas-107-30-2
NCGC00259124-01
tox21_201575
mom-cl
mom chloride
chloromethyl methyl ether, > 90%
chloromethylmethylether
chloromethyl methyl ether [mi]
chloromethyl methyl ether [hsdb]
CHEBI:82271 ,
(chloromethyl)methyl ether
chloromethyl (methyl)ether
momcl
clch2och3
chloromethyl methylether
chlormethyl methyl ether
methoxy methylchloride
methoxy methyl chloride
methyloxymethyl chloride
ch3och2cl
(chloromethyl) methyl ether
chloromethyl-methyl-ether
chloro(methyloxy)methane
chloro-methoxy-methane
chloro (methoxy)methane
(chloromethyl)methylether
chloromethyl-methylether
chloro (methoxy) methane
chloromethylm ethyl ether
chloromethyl-methyl ether
methyl choromethyl ether
chloromethoxy methane
1-chloro-1-methoxy-methane
chloromethymethyl ether
chloro(methoxy) methane
un 1239
CHEMBL3185256
F8881-7077
J-520019
mfcd00000885
GS-5886
methyl chloromethyl ether, anhydrous(dot)
chloro-methoxymethane
chloromethoxy-methane
BCP08223
Q158539
chloromethyl methyl ether, > 90per cent

Research Excerpts

Toxicity

ExcerptReferenceRelevance
"Exploration and expansion of the chemistries involving toxic or carcinogenic reagents are severely limited by the health hazards their presence poses."( Micro-total envelope system with silicon nanowire separator for safe carcinogenic chemistry.
Jang, S; Kim, DP; Ko, DH; Min, KI; Singh, AK; Vishwakarma, NK, 2016
)
0.43
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (1)

ClassDescription
etherAn organooxygen compound with formula ROR, where R is not hydrogen.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Protein Targets (7)

Potency Measurements

ProteinTaxonomyMeasurementAverage (µ)Min (ref.)Avg (ref.)Max (ref.)Bioassay(s)
acetylcholinesteraseHomo sapiens (human)Potency73.76580.002541.796015,848.9004AID1347398
GLI family zinc finger 3Homo sapiens (human)Potency13.01340.000714.592883.7951AID1259369; AID1259392
retinoic acid nuclear receptor alpha variant 1Homo sapiens (human)Potency23.14140.003041.611522,387.1992AID1159552; AID1159555
estrogen-related nuclear receptor alphaHomo sapiens (human)Potency31.50510.001530.607315,848.9004AID1224841; AID1224848; AID1224849; AID1259401; AID1259403
pregnane X nuclear receptorHomo sapiens (human)Potency56.62090.005428.02631,258.9301AID1346982
estrogen nuclear receptor alphaHomo sapiens (human)Potency15.58870.000229.305416,493.5996AID743069
thyrotropin-releasing hormone receptorHomo sapiens (human)Potency36.02620.154917.870243.6557AID1346891
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (8)

TimeframeStudies, This Drug (%)All Drugs %
pre-19900 (0.00)18.7374
1990's1 (12.50)18.2507
2000's3 (37.50)29.6817
2010's4 (50.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 48.75

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index48.75 (24.57)
Research Supply Index2.20 (2.92)
Research Growth Index4.86 (4.65)
Search Engine Demand Index69.84 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (48.75)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews1 (12.50%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other7 (87.50%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]